A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: mistake (35), fault (22), slip (31)

Methotrexate ver 1

Description
Chemotherapy Protocol HEAD AND NECK CANCER METHOTREXATE Regimen Head and Neck Cancer – Methotrexate Indication Advanced head and neck cancer WHO Performance
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Methotrexate-ver-1.pdf

HSCTRituximab_100mg-7day

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT RITUXIMAB 100mg (Weekly) Regimen • HSCT Allograft - Rituximab (7 day-100mg) Indications • EBV reactivation, PTLD and immune
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTRituximab-100mg-7day.pdf

GvHDProphylaxisMethotrexateTReplete

Description
Chemotherapy Protocol SUPPORT REGIMEN–GvHD PROPHYLAXIS METHOREXATE – T Replete Allograft Graft versus Host Disease (GvHD) Prophylaxis This regimen will only be
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/GvHDProphylaxisMethotrexateTReplete.pdf

GvHDProphylaxisMethotrexateTDepleted

Description
Chemotherapy Protocol SUPPORT REGIMEN– GvHD PROPHYLAXIS METHOREXATE – T Depleted Allograft GvHD PROPHYLAXIS This regimen will only be available to prescribe at
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/GvHDProphylaxisMethotrexateTDepleted.pdf

Pentostatin

Description
Chemotherapy Protocol HAIRY CELL LEUKEMIA PENTOSTATIN Regimen • HCL – Pentostatin Indication • Hairy cell leukaemia Toxicity Drug Pentostatin Adverse Effect Myelosupression, rash, fever
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/HCL/Pentostatin.pdf

CladribineSC

Description
Chemotherapy Protocol HAIRY CELL LEUKEMIA CLADRIBINE (SC) Regimen • HCL – Cladribine (SC) Indication • Hairy cell leukemia Toxicity Drug Cladribine Adverse Effect Skin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/HCL/CladribineSC.pdf

CladribineIV

Description
Chemotherapy Protocol HAIRY CELL LEUKEMIA CLADRIBINE (IV-5 day) Regimen • HCL – Cladribine (IV-5 day) Indication • Hairy cell leukaemia (this is
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/HCL/CladribineIV.pdf

Bevacizumab ver 1

Description
Chemotherapy Protocol CNS CANCER BEVACIZUMAB This protocol may require funding. This is an unlicensed indication for bevacizumab. Regimen CNS-Bevacizumab Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Bevacizumab-ver-1.pdf

CH001 SOP protocol verification

Description
Standard Operating Procedure Production of Chemotherapy Protocols (SOP:CH001) 1. Objective 1.1 The purpose of this standard operating procedure (SOP
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/CH001SOP-protocol-verification.pdf

Trastuzumab SC Ver 1.1

Description
Chemotherapy Protocol BREAST CANCER TRASTUZUMAB SC Regimen Breast Cancer – Trastuzumab SC Indication Treatment of metastatic breast cancer over expressing HER2 - as
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Trastuzumab-SC-Ver-1.1.pdf
81 to 90 of 630
Previous … 7 8 9 10 11 … Next